MiMedx Group Inc reports results for the quarter ended in June - Earnings Summary

MiMedx

31/07/2024 22:03

* MiMedx Group Inc  MDXG.OQ  reported quarterly adjusted
earnings
of 12 cents​​ per share for the quarter ended in June, higher
than the same quarter last year, when the company reported
breakeven earnings per share.  The mean expectation of
seven analysts for the quarter was for earnings of 8 cents per
share. Wall Street expected results to range from 5 cents to 10
cents per share.
    * Revenue rose 7.3% to $87.21 million from a year ago;
analysts
expected $88.92 million. 
    * MiMedx Group Inc's reported EPS for the quarter was 12
cents​.
    * The company reported quarterly net income of $17.62
million.
    * MiMedx Group Inc shares had risen by 9.5% this quarter and
lost 13.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.5%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for MiMedx Group Inc
is $12.00 
This summary was machine generated from LSEG data July 31 at
09:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.08                          
 Mar. 31 2024      0.05                          
 Dec. 31 2023                     0.32           
                   0.05           0.06           Beat